Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study Exploring Efficacy and Safety of Iodinated Activated Charcoal in COPD

NCT01404000 is registered in ClinicalTrials.gov with PharmaLundensis AB as lead sponsor.

NCT NCT01404000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01404000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study Exploring Efficacy and Safety of Iodinated Activated Charcoal in COPD
Lead sponsor
PharmaLundensis AB
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2011
Completion date
May 31, 2013
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive lung disease